Skip to main content
NCBI home page
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1995 Apr;114(2):361–372. doi: 10.1017/s095026880005799x

The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion.

C A Sabin 1, A N Phillips 1, C A Lee 1, G Janossy 1, V Emery 1, P D Griffiths 1
PMCID: PMC2271271  PMID: 7705496

Abstract

The effect of prior infection with cytomegalovirus (CMV) on progression of HIV disease in a cohort of 111 men with haemophilia was studied after 13 years follow-up. The relative hazards associated with CMV positivity on progression to AIDS, death and a CD4 count of 0.05 x 10(9)/l were 2.28, 2.42 and 2.34, respectively. CMV seropositive patients were significantly older than the seronegative and this was controlled for by using a Cox proportional hazards model. The relative hazards for the three endpoints decreased to 1.89, 1.82 and 1.93 respectively and were marginally non-significant (P = 0.05, 0.08 and 0.08 for the three endpoints respectively). We conclude that this cohort continues to show evidence of a 'co-factor' effect associated with prior infection with CMV which is confounded by age but not completely explained by age differences. The potential biological significance of these results is discussed in the context of recent controlled clinical trials which show a survival benefit from long-term high-dose acyclovir, a drug with activity in vivo against CMV and other herpesviruses.

Full text

PDF
361

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balfour H. H., Jr, Chace B. A., Stapleton J. T., Simmons R. L., Fryd D. S. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med. 1989 May 25;320(21):1381–1387. doi: 10.1056/NEJM198905253202105. [DOI] [PubMed] [Google Scholar]
  2. Becherer P. R., Smiley M. L., Matthews T. J., Weinhold K. J., McMillan C. W., White G. C., 2nd Human immunodeficiency virus-1 disease progression in hemophiliacs. Am J Hematol. 1990 Jul;34(3):204–209. doi: 10.1002/ajh.2830340310. [DOI] [PubMed] [Google Scholar]
  3. Berry N. J., Burns D. M., Wannamethee G., Grundy J. E., Lui S. F., Prentice H. G., Griffiths P. D. Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases. J Med Virol. 1988 Apr;24(4):385–393. doi: 10.1002/jmv.1890240405. [DOI] [PubMed] [Google Scholar]
  4. Berry N. J., Grundy J. E., Griffiths P. D. Radioimmunoassay for the detection of IgG antibodies to herpes simplex virus and its use as a prognostic indicator of HSV excretion in transplant recipients. J Med Virol. 1987 Feb;21(2):147–154. doi: 10.1002/jmv.1890210206. [DOI] [PubMed] [Google Scholar]
  5. Biggar R. J. AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters. AIDS. 1990 Nov;4(11):1059–1066. doi: 10.1097/00002030-199011000-00002. [DOI] [PubMed] [Google Scholar]
  6. Blaxhult A., Granath F., Lidman K., Giesecke J. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS. 1990 Feb;4(2):125–129. doi: 10.1097/00002030-199002000-00005. [DOI] [PubMed] [Google Scholar]
  7. Bofill M., Janossy G., Lee C. A., MacDonald-Burns D., Phillips A. N., Sabin C., Timms A., Johnson M. A., Kernoff P. B. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol. 1992 May;88(2):243–252. doi: 10.1111/j.1365-2249.1992.tb03068.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chevret S., Costagliola D., Lefrere J. J., Valleron A. J. A new approach to estimating AIDS incubation times: results in homosexual infected men. J Epidemiol Community Health. 1992 Dec;46(6):582–586. doi: 10.1136/jech.46.6.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cooper D. A., Pehrson P. O., Pedersen C., Moroni M., Oksenhendler E., Rozenbaum W., Clumeck N., Faber V., Stille W., Hirschel B. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group. AIDS. 1993 Feb;7(2):197–207. doi: 10.1097/00002030-199302000-00007. [DOI] [PubMed] [Google Scholar]
  10. Davis M. G., Kenney S. C., Kamine J., Pagano J. S., Huang E. S. Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8642–8646. doi: 10.1073/pnas.84.23.8642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gendelman H. E., Phelps W., Feigenbaum L., Ostrove J. M., Adachi A., Howley P. M., Khoury G., Ginsberg H. S., Martin M. A. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9759–9763. doi: 10.1073/pnas.83.24.9759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Griffiths P. D., Baboonian C. A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol. 1984 Apr;91(4):307–315. doi: 10.1111/j.1471-0528.1984.tb05915.x. [DOI] [PubMed] [Google Scholar]
  13. Griffiths P. D. Studies to define viral cofactors for human immunodeficiency virus. Infect Agents Dis. 1992 Oct;1(5):237–244. [PubMed] [Google Scholar]
  14. Jackson J. B., Erice A., Englund J. A., Edson J. R., Balfour H. H., Jr Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1. Transfusion. 1988 Mar-Apr;28(2):187–189. doi: 10.1046/j.1537-2995.1988.28288179029.x. [DOI] [PubMed] [Google Scholar]
  15. Kenney S., Kamine J., Markovitz D., Fenrick R., Pagano J. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1652–1656. doi: 10.1073/pnas.85.5.1652. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lee C. A., Phillips A., Elford J., Miller E. J., Bofill M., Griffiths P. D., Kernoff P. B. The natural history of human immunodeficiency virus infection in a haemophilic cohort. Br J Haematol. 1989 Oct;73(2):228–234. doi: 10.1111/j.1365-2141.1989.tb00257.x. [DOI] [PubMed] [Google Scholar]
  17. Meyers J. D., Reed E. C., Shepp D. H., Thornquist M., Dandliker P. S., Vicary C. A., Flournoy N., Kirk L. E., Kersey J. H., Thomas E. D. Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. N Engl J Med. 1988 Jan 14;318(2):70–75. doi: 10.1056/NEJM198801143180202. [DOI] [PubMed] [Google Scholar]
  18. Moss A. R., Bacchetti P., Osmond D., Krampf W., Chaisson R. E., Stites D., Wilber J., Allain J. P., Carlson J. Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) 1988 Mar 12;296(6624):745–750. doi: 10.1136/bmj.296.6624.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Phillips A. N., Elford J., Sabin C., Bofill M., Janossy G., Lee C. A. Immunodeficiency and the risk of death in HIV infection. JAMA. 1992 Nov 18;268(19):2662–2666. [PubMed] [Google Scholar]
  20. Phillips A. N., Lee C. A., Elford J., Janossy G., Timms A., Bofill M., Kernoff P. B. Serial CD4 lymphocyte counts and development of AIDS. Lancet. 1991 Feb 16;337(8738):389–392. doi: 10.1016/0140-6736(91)91166-r. [DOI] [PubMed] [Google Scholar]
  21. Phillips A. N., Lee C. A., Elford J., Webster A., Janossy G., Timms A., Bofill M., Kernoff P. B. More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. J Acquir Immune Defic Syndr. 1991;4(10):970–975. [PubMed] [Google Scholar]
  22. Phillips A. N., Sabin C. A., Elford J., Bofill M., Janossy G., Lee C. A. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection. BMJ. 1994 Jul 30;309(6950):309–313. doi: 10.1136/bmj.309.6950.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pillay D., Lipman M. C., Lee C. A., Johnson M. A., Griffiths P. D., McLaughlin J. E. A clinico-pathological audit of opportunistic viral infections in HIV-infected patients. AIDS. 1993 Jul;7(7):969–974. doi: 10.1097/00002030-199307000-00010. [DOI] [PubMed] [Google Scholar]
  24. Prentice H. G., Gluckman E., Powles R. L., Ljungman P., Milpied N., Fernandez Rañada J. M., Mandelli F., Kho P., Kennedy L., Bell A. R. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet. 1994 Mar 26;343(8900):749–753. doi: 10.1016/s0140-6736(94)91835-x. [DOI] [PubMed] [Google Scholar]
  25. Rabkin C. S., Hatzakis A., Griffiths P. D., Pillay D., Ragni M. V., Hilgartner M. W., Goedert J. J. Cytomegalovirus infection and risk of AIDS in human immunodeficiency virus-infected hemophilia patients. National Cancer Institute Multicenter Hemophilia Cohort Study Group. J Infect Dis. 1993 Nov;168(5):1260–1263. doi: 10.1093/infdis/168.5.1260. [DOI] [PubMed] [Google Scholar]
  26. Rugman F. P., Mannion P. T., Hay C. R., Bolton-Maggs P., Roberts D., Mutton K. J. Cytomegalovirus, serum beta 2 microglobulin, and progression to AIDS in HIV-seropositive haemophiliacs. Lancet. 1989 Sep 9;2(8663):631–631. doi: 10.1016/s0140-6736(89)90762-9. [DOI] [PubMed] [Google Scholar]
  27. Siddiqui A., Gaynor R., Srinivasan A., Mapoles J., Farr R. W. trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. Virology. 1989 Apr;169(2):479–484. doi: 10.1016/0042-6822(89)90177-3. [DOI] [PubMed] [Google Scholar]
  28. Webster A., Grundy J. E., Lee C. A., Emery V. C., Cook D. G., Kernoff P. B., Griffiths P. D. Cytomegalovirus infection and progression to AIDS. Lancet. 1989 Sep 16;2(8664):681–681. doi: 10.1016/s0140-6736(89)90928-8. [DOI] [PubMed] [Google Scholar]
  29. Webster A., Lee C. A., Cook D. G., Grundy J. E., Emery V. C., Kernoff P. B., Griffiths P. D. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet. 1989 Jul 8;2(8654):63–66. doi: 10.1016/s0140-6736(89)90312-7. [DOI] [PubMed] [Google Scholar]
  30. Youle M. S., Gazzard B. G., Johnson M. A., Cooper D. A., Hoy J. F., Busch H., Ruf B., Griffiths P. D., Stephenson S. L., Dancox M. Effects of high-dose oral acyclovir on herpesvirus disease and survival in patients with advanced HIV disease: a double-blind, placebo-controlled study. European-Australian Acyclovir Study Group. AIDS. 1994 May;8(5):641–649. doi: 10.1097/00002030-199405000-00010. [DOI] [PubMed] [Google Scholar]

Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES